Evidence map›Paper›PMID 26609181›Full record

ArticleJournal of nuclear medicine : official publication, Society of Nuclear Medicine2016

RGD PET: From Lesion Detection to Therapy Response Monitoring.

Gang Niu, Xiaoyuan Chen

Abstract readComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Pretreatment PET/CT imaging of angiogenesis based onEuropean journal of nuclear medicine and molecular imaging · 2019
    Trial
  2. Peptide-based drugs in immunotherapy: current advances and future prospects.Medical oncology (Northwood, London, England) · 2025
    Review
  3. Review
  4. Review
  5. Angiogenesis-TargetedNuclear medicine and molecular imaging · 2021
    Article
  6. Article
  7. [Molecular imaging and biology · 2019
    Article
  8. European journal of nuclear medicine and molecular imaging · 2016
    Article
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Gang NiuLaboratory for Molecular Imaging and Nanomedicine (LOMIN), Institute of Biomedical Imaging and Bioengineering (NIBIB), the National Institutes of Health (NIH), Bethesda, Maryland.
Xiaoyuan ChenLaboratory for Molecular Imaging and Nanomedicine (LOMIN), Institute of Biomedical Imaging and Bioengineering (NIBIB), the National Institutes of Health (NIH), Bethesda, Maryland shawn.chen@nih.gov.

Funding

Laboratory of Molecular Imaging and NanomedicineZIAEB000073 · NIBIB · NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING · PI CHEN, XIAOYUAN · 2010 to 2020
$32.8M
Intramural NIH HHS Z99 EB999999Intramural NIH HHS ZIA EB000073
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

RadiopharmaceuticalsBrain NeoplasmsChemoradiotherapyCoordination ComplexesFemaleGlioblastomaHumansMalePeptides, CyclicCoordination ComplexesPeptides, CyclicRadiopharmaceuticals

Identifiers

PMID26609181
PMCPMC5241674

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.